狂犬病诊断市场、机会、成长动力、产业趋势分析与预测，2024-2032

在对可靠、准确的诊断方法的需求不断增长的推动下，全球狂犬病诊断市场预计在 2024 年至 2032 年间以 4.7% 的复合年增长率扩张。狂犬病是一种致命的病毒性疾病，继续对公共卫生构成重大挑战，特别是在低收入和中等收入国家。世界卫生组织 (WHO) 报告称，狂犬病每年导致数万人死亡，其中大多数发生在亚洲和非洲。随着人们越来越关注早期和准确的疾病检测，先进的狂犬病诊断方法的采用将显着增加，从而支持市场成长。

整个狂犬病诊断产业根据测试类型、技术、样本类型、最终用途和地区进行分类。

到 2032 年，色谱细分市场将占据狂犬病诊断市场的重要份额。该技术能够分离和分析复杂的生物样品，使其成为狂犬病检测的首选。狂犬病在各个地区的盛行率不断上升，加上对先进诊断技术的需求，正在推动色谱法在狂犬病诊断中的采用。此外，色谱技术的不断进步和创新将提高狂犬病检测的效率和准确性。

诊断实验室领域将在预测期内大幅成长。诊断实验室在狂犬病的早期检测和管理中发挥着至关重要的作用，提供专业的检测服务以确保准确和及时的诊断。狂犬病发病率的上升，特别是在流行地区，导致对诊断服务的需求增加，从而推动了这一领域的成长。此外，不断扩大的实验室网路和严格的品质控制措施的实施导致狂犬病检测对诊断实验室的依赖日益增加。随着对可靠和标准化诊断服务的需求不断增加，这种趋势将持续下去。

在强大的医疗基础设施、大量研发投资以及公众对狂犬病预防和控制的高度认识的支持下，欧洲狂犬病诊断市场将在 2024 年至 2032 年实现可观的增长。该地区完善的诊断设施和强有力的监管框架确保了诊断测试的品质和可靠性。此外，旨在根除狂犬病的政府倡议以及欧洲领先诊断公司的存在正在进一步推动创新和市场扩张。因此，欧洲仍将是狂犬病诊断的关键地区，为全球市场成长做出重大贡献。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 动物咬伤案件不断增加
    • 被忽视的热带疾病（NTDS）盛行率不断上升
    • 诊断技术的进步
    • 政府优惠政策
  • 产业陷阱与挑战
    • 测试成本高
• 成长潜力分析
• 监管环境
• 技术景观
• 波特的分析
• PESTEL分析
• 未来市场趋势

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按测试类型，2021 - 2032 年

• 主要趋势
• 萤光抗体测试（FAT）
• 免疫组化检测
• 扩增方法
• 组织学检查
• 血清学测试

第 6 章：市场估计与预测：按技术分类，2021 - 2032 年

• 主要趋势
• 酵素连结免疫吸附试验
• 色谱法
• 聚合酶炼式反应
• 其他技术

第 7 章：市场估计与预测：按样本类型，2021 - 2032

• 主要趋势
• 脑组织
• 唾液
• 脑脊髓液（CSF）
• 血液（血清）
• 其他样品类型

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院和诊所
• 诊断实验室

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Abbexa Ltd
• Aviva Systems Biology Corporation
• BIONOTE Co., LTD
• Bio-Rad Laboratories, Inc.
• Creative Diagnostics
• Demeditec Diagnostics GmbH
• Merck KGaA
• MyBioSource, Inc.
• Norgen Biotek Corp.
• Thermo Fisher Scientific Inc.

Global Rabies Diagnostics Market is poised to expand at a 4.7% CAGR between 2024 and 2032, fueled by the increasing demand for reliable and accurate diagnostic methods. Rabies, a fatal viral disease, continues to pose significant public health challenges, particularly in low- and middle-income countries. The World Health Organization (WHO) reports that rabies leads to tens of thousands of fatalities annually, with the majority occurring in Asia and Africa. With the growing focus on early and accurate disease detection, the adoption of advanced rabies diagnostics will rise significantly, supporting market growth.

The overall rabies diagnostics industry is categorized based on Test Type, Technology, Sample Type, End-use, and Region.

The chromatography segment will capture a significant share of the rabies diagnostics market by 2032. Chromatography technology is gaining prominence in rabies diagnostics due to its ability to deliver precise and rapid results. This technology enables the separation and analysis of complex biological samples, making it a preferred choice for rabies detection. The increasing prevalence of rabies in various regions, coupled with the need for advanced diagnostic techniques, is driving the adoption of chromatography in rabies diagnostics. Furthermore, ongoing technological advancements and innovations in chromatography will enhance the efficiency and accuracy of rabies testing.

The diagnostic laboratories segment will grow substantially over the forecast period. Diagnostic laboratories play a crucial role in the early detection and management of rabies, offering specialized testing services that ensure accurate and timely diagnosis. The rising incidence of rabies, particularly in endemic regions, has led to an increased demand for diagnostic services, thereby driving the growth of this segment. Additionally, the expanding laboratory networks and the implementation of stringent quality control measures contribute to the growing reliance on diagnostic laboratories for rabies testing. This trend will continue as the need for reliable and standardized diagnostic services intensifies.

Europe rabies diagnostics market will achieve commendable growth through 2024-2032, supported by a robust healthcare infrastructure, substantial investment in research and development, and a high level of public awareness regarding rabies prevention and control. The region's well-established diagnostic facilities and strong regulatory frameworks ensure the quality and reliability of diagnostic tests. Moreover, government initiatives aimed at eradicating rabies and the presence of leading diagnostic companies in Europe are further driving innovation and market expansion. As a result, Europe will remain a key region for rabies diagnostics, contributing significantly to global market growth.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising cases of animal bites
    • 3.2.1.2 Increasing prevalence of neglected tropical diseases (NTDS)
    • 3.2.1.3 Technological advancements in diagnostics
    • 3.2.1.4 Favorable government policies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of test
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Fluorescent antibody test (FAT)
• 5.3 Immunohistochemical test
• 5.4 Amplification methods
• 5.5 Histologic examination
• 5.6 Serology tests

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 ELISA
• 6.3 Chromatography
• 6.4 PCR
• 6.5 Other techniques

Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Brain tissue
• 7.3 Saliva
• 7.4 Cerebrospinal fluid (CSF)
• 7.5 Blood (Serum)
• 7.6 Other sample types

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals and clinics
• 8.3 Diagnostic laboratories

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbexa Ltd
• 10.2 Aviva Systems Biology Corporation
• 10.3 BIONOTE Co., LTD
• 10.4 Bio-Rad Laboratories, Inc.
• 10.5 Creative Diagnostics
• 10.6 Demeditec Diagnostics GmbH
• 10.7 Merck KGaA
• 10.8 MyBioSource, Inc.
• 10.9 Norgen Biotek Corp.
• 10.10 Thermo Fisher Scientific Inc.